pfizer

FDA approves larger dose of Pfizer’s Aricept (AP)

AP - Drugmakers Eisai Inc. and Pfizer Inc.

Read more here:
FDA approves larger dose of Pfizer’s Aricept
(AP)

pfizer

Eisai say FDA approves higher dose Aricept (Reuters)

Reuters - Eisai Co and Pfizer Inc said they won U.S. regulatory approval for a higher dose once-daily version of Aricept, a drug that treats Alzheimer disease.

View original post here:
Eisai say FDA approves higher dose Aricept
(Reuters)

pfizer

Pfizer gets EU approval for kids’ cholesterol drug (AP)

AP - The European Union has approved a new chewable form of cholesterol blockbuster Lipitor for children 10 and up with high levels of bad cholesterol and triglycerides, a type of blood fat, Pfizer said Tuesday.

Read the original here:
Pfizer gets EU approval for kids’ cholesterol drug
(AP)

pfizer

Pfizer halts heart failure trial early for benefit (Reuters)

Reuters - Pfizer Inc said on Thursday it is halting recruitment of patients into a heart failure clinical study involving its drug Inspra because the study reached its main efficacy goal early.

View original post here: 
Pfizer halts heart failure trial early for benefit
(Reuters)

pfizer

Pfizer pneumonia shot helps HIV-infected patients (Reuters)

Reuters - Results of a trial of Pfizer’s Prevnar 7 vaccine against a major cause of pneumonia and meningitis showed on Wednesday that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.

Read the original:
Pfizer pneumonia shot helps HIV-infected patients
(Reuters)

pfizer

Pfizer says FDA OKs updated infection vaccine (AP)

AP - Pfizer said Wednesday the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for infants and children.

Continued here: 
Pfizer says FDA OKs updated infection vaccine
(AP)

pfizer

Ratiopharm fields decisive takeover bids-sources (Reuters)

Reuters - Generic-drug makers Teva and Actavis, backed by Swedish buyout firm EQT, have placed make-or-break bids for German peer Ratiopharm but drug major Pfizer is expected to also be a contender, sources said.

Read more from the original source: 
Ratiopharm fields decisive takeover bids-sources
(Reuters)

pfizer

Pfizer ends late-stage lung-cancer study (Reuters)

Reuters - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving overall survival.

Read more: 
Pfizer ends late-stage lung-cancer study
(Reuters)

pfizer

Statins don’t curb colorectal cancer risk (Reuters)

Reuters - Taking a cholesterol-lowering statin will lower your cholesterol but it won’t cut your risk of developing colorectal cancer, according to study of more than 400,000 Canadians.

Originally posted here:
Statins don’t curb colorectal cancer risk
(Reuters)

pfizer

FDA reviews update to Pfizer vaccine for kids (AP)

AP - Federal health officials on Monday questioned whether to approve an updated version of Pfizer’s best-selling anti-infection vaccine for children, despite company studies that failed to meet certain goals.

More here:
FDA reviews update to Pfizer vaccine for kids
(AP)

Next Page »